Clinical
RSSArticles
-
Feds Greenlight Expanded Naloxone Availability
The FDA has approved the nasal spray version of the opioid overdose reversal agent for over-the-counter sales.
-
Bone Density as a Dementia Risk Indicator
Researchers found some associations between bone density loss and a higher risk of developing dementia.
-
Healthy Lifestyle Behaviors Linked to Slower Memory Decline
In a population-based, prospective cohort study of 29,000 Chinese adults, researchers found healthy lifestyle was associated with slower memory decline, even in the presence of the apolipoprotein E4 allele.
-
Self-Treatment of Recurrent Benign Paroxysmal Positional Vertigo
Using a cell phone-based app, self-treatment of recurrent benign positional paroxysmal vertigo was feasible and effective in most patients.
-
Does COVID Vaccination Prevent Car Crashes?
In a large study, lack of COVID vaccination was associated with more incidents of car crash injuries.
-
Long-Term Maintenance Therapy After Percutaneous Coronary Intervention
An extended six-year follow-up of the HOST-EXAM study revealed the consistent benefit of the primary endpoint of fewer major cardiovascular events and less bleeding with clopidogrel vs. low-dose aspirin monotherapy in post-percutaneous coronary intervention patients who were on dual antiplatelet therapy for one year.
-
Sparsentan Tablets (Filspari)
Sparsentan can be prescribed to alleviate proteinuria in adults with primary immunoglobulin A nephropathy who are at risk of rapid disease progression — generally, a urine protein-to-creatinine ratio 1.5 mg/g or higher.
-
Tool Identifies Patients in Need of Serious Illness Conversations
Text messages generated by a machine-learning tool resulted in clinicians engaging in more serious illness conversations with high-risk patients.
-
Bias and Stigma Hinder Effective Obesity Treatment
The industry is moving away from a hierarchy of care where a primary provider tells the patient what they ought to do. Instead, the model is moving toward shared decision-making.
-
CDC: Candida auris Spreading at ‘Alarming’ Rate
The agency reported the number of clinical cases has risen each year since 2016, with the worst spike occurring during the 2020-2021 period.